The current landscape of clinical trials is quickly evolving, spurred by novel approaches to therapeutic creation. From tailored medicine, leveraging genetic data to inform treatment approaches, to the assessment of complex immunotherapies, practitioners are witnessing a paradigm shift in how we address disease. A essential focus remains on opti… Read More